About Platypus Technologies
Platypus Technologies is a company based in Madison (United States) founded in 2000. Platypus Technologies has raised $154.05 thousand across 17 funding rounds from investors including HHS and National Science Foundation. Platypus Technologies operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
- Headquarter Madison, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website platypustech.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$154.05K (USD)
in 17 rounds
- Latest Funding Round$205.1K (USD), Grant
Feb 2022
- InvestorsHHS
& 1 more
Apps and channels of Platypus Technologies
its YouTube channel Platypus Technologies has 24 subscribers.
Funding Insights of Platypus Technologies
Platypus Technologies has successfully raised a total of $154.05K across 17 strategic funding rounds. The most recent funding activity was a Grant round of $205.1 thousand completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $154,046
- Total Rounds 17
- Last Round Grant — $205,103
- First Round $399,939
(Feb 2009)
- Investors Count 2
Latest 10 of 17 funding rounds of Platypus Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $205,103 | Grant | – | – | |
| Sep 2020 | $149,951 | Grant | – | – | |
| Aug 2016 | $150,635 | Grant | – | – | |
| Feb 2016 | $1.13M | Grant | – | – | |
| Aug 2014 | $144,340 | Grant | – | – | |
| Jul 2014 | $147,446 | Grant | – | – | |
| Mar 2014 | $154,046 | Unspecified | – | – | – |
| Sep 2012 | $448,830 | Grant | – | – | |
| Jul 2012 | $149,986 | Grant | – | – | |
| Jun 2012 | $149,986 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Platypus Technologies
Platypus Technologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
- | – | nsf.gov | - |
Investor details for Platypus Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Platypus Technologies
3 dated milestones of Platypus Technologies across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Platypus Technologies is founded.
- Funding First funding round of $400K.
- Funding Latest funding round, Grant, of $205K.
Competitors of Platypus Technologies
Platypus Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cellply.com | 2013 | Bologna, Italy | $8.05M | – | Developer of in-vitro diagnostic products for the detection of cancer | |
| lucidsci.com | 2012 | Atlanta, United States | $12.73M | – | Real-time cell analyzers are developed for oxygen consumption monitoring. | |
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | – | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | |
| cytotronics.com | 2015 | Boston, United States | $22.75M | 22 | Cell-based assays for drug discovery are developed via CMOS platform. | |
| saguarobio.com | 2020 | Quebec, Canada | $4.1M | 4 | 3D cell culture products are developed for drug discovery applications. | |
| remedyplan.com | 2011 | – | $24.7M | – | Metastatic cancer properties are targeted by Remedy Plan's containment therapy. | |
| indigobiosciences.com | 2005 | State College, United States | $1.28M | 17 | Nuclear receptor and in vitro toxicology solutions are provided. | |
| skplasma.com | 1970 | Seongnam-si, South Korea | – | – | Plasma derivatives are produced via fractionation and purification processes. | |
| discoverx.com | 2000 | Birmingham, United Kingdom | $13.4M | – | Develops cell-based assays and provides services for drug discovery and development. | |
| pelagobio.com | 2013 | Solna, Sweden | – | – | Drug-target interactions are quantified via specialized assay services. |
Detailed competitors of Platypus Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Platypus Technologies
The website of Platypus Technologies (platypustech.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▼ 19.6% vs previous month
Websites whose visitors overlap most with Platypus Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abdesignlabs.com | 100% | 4.7K | #4,128,811 | View details | |
cellmigration.org | cellmigration.org | 98% | – | #15,153,012 | – |
| biossusa.com | 96% | 680.7K | #1,034,016 | View details | |
| tedpella.com | 93% | – | #469,746 | View details | |
| f1000.com | 93% | 36.1K | #932,819 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Platypus Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Platypus Technologies
10 companies that operate in the same segment as Platypus Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Platypus Technologies
Platypus Technologies was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Platypus Technologies is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Platypus Technologies is a funded company, having raised a total of $154.05K across 17 funding rounds to date. The company's 1st funding round was a Grant of $149.99K, raised on Feb 2009.
Platypus Technologies was founded in 2000 in Madison, United States, within the biotechnology sector. A proprietary cell-based assay platform has been designed to monitor cell migration through cell-free zones created by stoppers. Cell invasion assays are also produced using collagen-coated zones. Hydrogen sulfide sensors, metal films, chips, and related accessories are manufactured as additional products for scientific and industrial use.
Platypus Technologies's top competitors include CytoTronics, Kiyatec and Remedy Plan.
Platypus Technologies has 2 investors. Key investors include HHS, and National Science Foundation.